Optimizing healthcare at the population level: results of the improving cardiovascular outcomes in nova scotia partnership.

Optimizing healthcare at the population level: results of the improving cardiovascular outcomes in nova scotia partnership. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Optimizing healthcare at the population level: results of the improving cardiovascular outcomes in nova scotia partnership. Abstract Text:

Jafna Cox,David Johnstone,Joanna Nemis-White,Terrence Montague,

Disease management is increasingly considered a valid strategy in the chronic care of our aging patient populations with multiple diseases. The Improving Cardiovascular Outcomes in Nova Scotia (ICONS) project examined whether a community-oriented health management partnership would lead to enhanced care and improved outcomes across an entire healthcare system. ICONS was a prospective cohort study, with baseline and repeated measurements of care and outcomes fed back to all project partners, along with other interventions aimed at optimizing care; preceding interval cohorts served as controls to post-intervention cohorts. The setting was the province of Nova Scotia, whose population is approximately 950,000. All 34,060 consecutive adult patients hospitalized in Nova Scotia with acute myocardial infarction (AMI(, unstable angina (UA) or congestive heart failure (CHF) October 1997-March 2002 were included. Interventions were a combination of serial audits and feedbacks of practices and outcomes, web-based publication of findings, newsletter-based education and reminders, physician small-group workshops, pharmacy monitoring and compliance programs, care maps, algorithms, discharge forms and patient information cards. Rates of use of evidence-based marker therapies were the primary outcome measure. Secondary measures included one-year, all-cause mortality and re-hospitalization. Evidence-based prescription practices, for all target diseases, continuously and markedly improved over time. At the population level, there were no changes in one-year mortality for any disease state, although use of proven therapies predicted survival at the individual level throughout the five-year period for all disease states. Rates of re-hospitalization decreased significantly for all disease states over the course of ICONS; but most traditional positive and negative predictors of this outcome, like advanced age and use of proven therapies, respectively, were not predictive. ICONS demonstrated that provider prescribing patterns and patient re-hospitalization rates were continuously improved in three disease states and across an entire health system, through a community partnership model of disease management that was sustained over a long time. Further studies are needed to better understand the drivers and modifiers of patient outcomes at the population level.

Optimizing healthcare at the population level: results of the improving cardiovascular outcomes in nova scotia partnership. Publishing Authors By Initials

J Cox,D Johnstone,J Nemis-White,T Montague,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Optimizing healthcare at the population level: results of the improving cardiovascular outcomes in nova scotia partnership. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Healthcare quarterly (Toronto, Ont.)

VOLUME: 11

Page Numbers: 28-41

Journal Abbreviation:

ISSN: 1710-2774

DAY: 25

MONTH: 03

YEAR: 2008

Optimizing healthcare at the population level: results of the improving cardiovascular outcomes in nova scotia partnership. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 101208192

Optimizing healthcare at the population level: results of the improving cardiovascular outcomes in nova scotia partnership. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Optimizing healthcare at the population level: results of the improving cardiovascular outcomes in nova scotia partnership. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Optimizing healthcare at the population level: results of the improving cardiovascular outcomes in nova scotia partnership.

AFFILIATION: MD, Director of Research, Division of Cardiology, and Professor, Departments of Medicine and Community Health and Epidemiology, Dalhousie University, Halifax, Nova Scotia.

Country: Canada

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Healthc Q

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Optimizing healthcare at the population level: results of the improving cardiovascular outcomes in nova scotia partnership Related Publications

• Cause-specific noncardiac mortality in patients with congestive heart failure--a contemporary Canadian audit. Clinical Quality Improvement Network (CQIN) Investigators.
• Clinical efficacy of emergency bypass surgery for failed coronary angioplasty.
• Contemporary disease management in Quebec.
• Contemporary medical management of left ventricular dysfunction and congestive heart failure.
• Effects of long term cholesterol lowering on coronary atherosclerosis in patient risk factor subgroups: the Simvastatin/enalapril Coronary Atherosclerosis Trial (SCAT).
• Elective irradiation with the electron beam after mastectomy for breast cancer.
• Electromagnetic implantable middle ear hearing device of the ossicular-stimulating type: principles, designs, and experiments.
• Geriatric aspects of rectal diseases.
• Home training for preschool deaf children through correspondence.
• Human ecchordosis physaliphora and chick embryonic notochord. A comparative electron microscopic study.
• In vivo skeletal muscle metabolism during dynamic exercise and recovery: assessment by nuclear magnetic resonance spectroscopy.
• Long term clinical outcomes following isolated mitral valve replacement.
• Long term follow-up after isolated aortic valve replacement.
• Malignant masses in the therapeutically irradiated breast.
• Metabolism of normal skeletal muscle during dynamic exercise to clinical fatigue: in vivo assessment by nuclear magnetic resonance spectroscopy.
• Neural signature of fictive learning signals in a sequential investment task.
• Nonpharmacologic treatment of erectile dysfunction.
• Nonrheumatic atrial fibrillation: a brief overview.
• Optimizing healthcare at the population level: results of the improving cardiovascular outcomes in nova scotia partnership.
• Penile prosthesis implantation for end-stage erectile dysfunction after radical prostatectomy.
• Proceedings: Radiotherapy of breast cancer: guidelines according to features of disease.
• Q-wave infarction: pathophysiology of body surface potential map and ventriculographic patterns in anterior and inferior groups.
• Quantitative relation of electrocardiographic and angiocardiographic measures of risk in patients with coronary atherosclerosis. Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT) Investigators.
• Rationale and design features of a clinical trial examining the effects of cholesterol lowering and angiotensin-converting enzyme inhibition on coronary atherosclerosis: Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT). SCAT Investigators.
• Recognition memory as a function of encoding strategy and stimulus codability.
• Short-term memory traces for action bias in human reinforcement learning.
• The changing clinical profile of coronary artery bypass graft patients, 1970-89.
• The first wave.
• The treatment and prevention of coronary heart disease in Canada: do older patients receive efficacious therapies? The Clinical Quality Improvement Network (CQIN) Investigators.
• The utilization of antithrombotic prophylaxis for atrial fibrillation in a geriatric rehabilitation hospital.